Gene Query: RRP9

Dataset Description Geneva Score
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 70.43
Cajal bodies are linked to genome conformation [RNA-Seq] 27.27
Cajal bodies are linked to genome conformation 27.27
Survival of pancreatic cancer cells lacking KRAS function 27.2
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 27.07
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 25.79
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 25.54
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 23.61
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 23.35
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 22.14
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 22.14
The landscape of alternative splicing in aggressive prostate cancers 22.08
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 21.57
Regulating Interleukin-2 activity with engineered receptor signaling clamps 21.44
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 21.43
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 20.5
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 20.39
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 19.94
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 19.36
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 18.4
Identification of Sin3B regulated genes during quiescence 17.95
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 17.86
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 17.22
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 17.21
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 16.93
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 16.89
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 16.89
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 16.52
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 16.52
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 16.25
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 16.25
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 15.61
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 15.45
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 15.37
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 15.24
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 15.17
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 14.56
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 14.42
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 14.42
Global gene expression profile of dasatinib-resistant RCH-ACV cells 13.88
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 13.8
RNA-seq analysis of control and Myc-induced U2OS cells 13.64
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 13.58
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 13.31
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 13.27
Gene expression profiling of leukemia cells following asparagine depletion 12.91
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 12.87
Mechanistic Model-Guided Study of Embryonic Morphogenesis 12.63
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 12.59
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 12.58
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 12.55
Transcriptome of activated human and mouse MAIT cells 12.42
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 12.34
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 11.9
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.78
The cohesin complex prevents Myc-induced replication stress 11.72
p53 activity results in DNA replication fork processivity 11.71
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 11.47
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 11.43
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 11.36
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 11.36
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 11.28
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 11.27
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 11.24
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 11.24
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.2
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 11.19
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 11.16
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 10.84
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 10.81
ETV7 and interferon response 10.73
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 10.73
Effect of FGF13 depletion on the H460 cell line 10.7
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 10.68
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 10.58
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 10.54
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 10.49
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 10.46
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 10.46
Differential gene expression of human melanoma cells [RNA-seq] 10.38
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.38
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 10.24
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 10.13
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.1
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.1
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 10.09
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.9
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.87
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 9.79
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.64
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 9.53
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 9.42
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 9.41
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 9.41
Real-time observation of light-controlled transcription in living cells 9.39
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.33
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.32
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 9.29
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 9.27
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 9.27
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 9.25
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 9.19
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 9.09
Functional role of SLIT2 and ROBO1 in trophoblasts 9.06
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 9.05
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 8.99
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.92
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.92
A single cell reference map for human blood and tissue T cell activation 8.77
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 8.65
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 8.65
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 8.65
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.59
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 8.56
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 8.49
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 8.46
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 8.46
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 8.41
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.36
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.36
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 8.29
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 8.12
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.08
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 8.04
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 8.04
DIGIT regulates endoderm differentiation of human embryonic stem cells 7.89
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 7.81
R430: A potent inbibitor of DNA and RNA viruses 7.72
Seletive inhibition of CDK9 in DLBCL cell lines 7.69
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.61
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.61
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.61
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 7.58
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 7.56
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 7.55
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 7.55
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.45
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.45
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.43
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 7.42
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 7.42
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.4
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.39
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.34
High-throughput sequencing of pluripotent cells 7.33
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 7.3
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.3
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 7.23
Glioblastoma stem cells infected by ZIKA virus 7.22
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 7.17
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 7.14
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 7.1
AUF-1 affected genes in human skin cells 7.09
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 7.07
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 7.05
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 7.05
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 7.05
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.01
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 6.94
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 6.88
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 6.88
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 6.87
Single-nucleotide-resolution mapping of HBV promoters using CAGE 6.81
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 6.79
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 6.78
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 6.78
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 6.77
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 6.77
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 6.77
Silencing SPIB in attached and floating state of H1703 lung cancer cells 6.74
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.73
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 6.72
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.7
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 6.66
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.65
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 6.61
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 6.61
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 6.6
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 6.59
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.57
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.57
RNA-seq of resting and activated CD4+ T cells +-JQ1 6.56
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 6.54
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 6.51
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 6.49
Paxillin regulates genomic networks in prostate cancer [PC3] 6.39
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 6.37
Impact of dieldrin on transcription in Jurkat T cells 6.35
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.35
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.29
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 6.29
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.26
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.25
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.21
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.19
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 6.19
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 6.19
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 6.15
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.07
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.06
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 6.03
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 6.02
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.02
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.99
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.99
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 5.97
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.96
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.96
LncRNA-GAS5 negative regulation of YAP-target genes expression 5.96
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 5.96
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.95
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.95
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.92
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.92
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 5.92
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 5.9
Genome wide miR-191 target profile determined by RIP and gene expression profiling 5.9
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.88
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.88
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.87
U1 snRNP telescripting regulates size-function stratified human genome 5.84
RNA-seq analysis of BAP1-depleted uveal melanoma cells 5.81
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 5.79
FOXD3 is a novel tumor suppressor in lung cancer 5.76
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 5.74
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.73
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.71
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.7
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.7
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.69
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.62
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.61
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 5.6
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 5.57
Polarized B -cell functions 5.53
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.51
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 5.49
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 5.49
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.46
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 5.46
Transcriptome analysis of SKI knock-out in HL60 cells 5.46
PRDM1 inhibits proliferation of human colon cancer organoids 5.45
DART-seq: an antibody-free method for global m6A detection 5.44
Illumina Total RNA-seq in HeLa 5.44
RNA seq with AML (NB4) cells upon FTO inhibition 5.42
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 5.42
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.42
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.42
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.36
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 5.36
A map of gene expression in neutrophil-like cell lines 5.34
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 5.33
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 5.31
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.29
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.25
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.22
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.22
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.22
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 5.14
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 5.14
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.14
Overexpression and knockdown experiment for circCSNK1G3 5.13
RNA-seq of naive and primed ES cells 5.12
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.12
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.09
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.09
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.05
Global transcriptome analysis of HAP1 cells 5.04
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.04
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 5.03
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.99
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.97
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.96
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.95
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.94
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.9
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.89
FBXW7 modulates stress response by post-translational modification of HSF1 4.85
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.85
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 4.85
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.83
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.77
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.68
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.68
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.62
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.62
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.57
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.54
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.49
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 4.48
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 4.42
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.38
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.34
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 4.26
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 4.26
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.14
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 4.12
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.12
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.1
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.1
RNA splicing alteration on glioblastoma and normal neural stem cells 4.06
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.04
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 4.01
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 4.01
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 3.99
Functional significance of the HIV-1 Tat signature amino acid residues 3.99
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 3.97
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.96
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.96
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.95
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.93
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.91
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.91
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.9
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.9
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.88
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.86
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.85
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.77
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.75
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.75
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.72
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.72
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.72
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.68
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.65
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.63
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.62
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.6
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.54
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.54
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.54
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.52
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 3.5
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.48
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.48
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.46
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.44
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.41
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.4
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.36
Transcriptomic analysis of LSD1 3.36
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.35
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.35
N6-methyladenine DNA Modification in Glioblastoma 3.29
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.29
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 3.26
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 3.26
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.24
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.23
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.18
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.18
Cell responses to dysregulated VZV-induced cell-cell fusion 3.17
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.14
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.08
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.02
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.02
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.98
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.97
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.96
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 2.96
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.93
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.93
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.84
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 2.78
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.78
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.76
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.75
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.75
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.69
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 2.67
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.61
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.6
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.59
U2AF1 mutations alter splice site recognition in hematological malignancies 2.57
RNA editing in nascent RNA affects pre-mRNA splicing 2.51
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.51
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.51
Transcriptome sequencing of K-562 cells 2.5
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 2.46
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.44
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 2.44
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.42
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.39
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.37
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 2.37
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.34
RNA-seq analysis upon ARID1B overexpression 2.33
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.27
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.26
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.24
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.2
Function and hormonal regulation of GATA3 in human first trimester placentation 2.18
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.17
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.15
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.15
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.1
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.04
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.03
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.03
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.03
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.03
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.0
Human Treg IFNg/IL-10 subpopulations 1.99
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.98
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.97
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.91
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.85
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.84
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.84
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.83
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.82
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.81
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.8
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.77
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.71
H1609088 Human RNA-Sequencing 1.71
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.68
Comparative Analysis of Cas9 Activators Across Multiple Species 1.68
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.65
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.63
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.63
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.6
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.58
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.58
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.58
Loss of CREBBP results in gene expression repression in lymphoma cells 1.5
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.5
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.49
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.48
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.46
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.45
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.45
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.4
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.38
KSDM1b Role in Ewing Sarcoma 1.37
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.34
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 1.32
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.3
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.26
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.26
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.26
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.26
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.23
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.16
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.14
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 1.06
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.06
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 1.05
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.01
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.01
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 0.94
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.9
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.89
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.87
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.83
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.82
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.81
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.8
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.79
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.79
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.79
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.76
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.76
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.73
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.69
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.61
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.6
Myc activation coordinates gene transcription and protein translation responses 0.56
Gene expression changes due to PARP knockdown in human cells 0.53
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.51
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.48
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.45
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.45
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.4
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.39
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.37
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.37
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.34
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.32
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.3
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.3
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.27
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.26
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.26
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.26
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.14
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.11
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.07
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.06
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.03
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.03
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.03
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation